Skip to main content

Day: May 6, 2022

Skylight Health Completes Largest Acquisition to date and Enters Medicare Advantage Global Risk

Skylight doubles top line revenue and adds over 5,000 patient livesNeighborMD (“NMD”) adds 9 practices across Central and Southern Florida with over 2,400 owned and affiliated global capitated risk lives. Unaudited trailing 12 months (TTM) primary care revenue of US $35 million roughly evenly split between owned and affiliate practices, which more than doubles current Skylight revenue run rate Secured US $20 million debt facility with FLC Credit Partners (“FLC”), a New York based lender All key leadership and operational teams will continue with Skylight, bringing a successful 5-year track record of generating a surplus under Medicare Advantage (“MA”) risk contracts Company plans to expand risk contracts to existing Medicare members in Florida and expansion of payors with the recent Joint Venture announcement with Collaborative Health...

Continue reading

DraftKings Reports First Quarter Revenue of $417 Million; First Quarter B2C Segment Revenue Increases 44% YOY and Company-Wide Adjusted EBITDA Exceeds Midpoint of Guidance by More Than 12%

Raises 2022 guidance for both revenue and Adjusted EBITDA based on continued strong customer behavior and optimization of cost structure BOSTON, May 06, 2022 (GLOBE NEWSWIRE) — DraftKings Inc. (Nasdaq: DKNG) (“DraftKings” or the “Company”) today reported its first quarter 2022 financial results. First Quarter 2022 Highlights For the three months ended March 31, 2022, DraftKings reported revenue of $417 million, an increase of 34% compared to $312 million during the same period in 2021. Revenue for the Company’s B2C segment grew to $404 million, an increase of 44% compared to the three months ended March 31, 2021. Adjusted EBITDA outperformed the midpoint of the guidance for the first quarter of 2022 previously provided by DraftKings during its fourth quarter earnings conference call on February 18, 2022 by more than 12%. “DraftKings...

Continue reading

Dorel Reports First Quarter 2022 Results

Dorel Juvenile revenue increases in most markets Dorel Home impacted by reduced demand Profitability reduced by pressure on marginsMONTREAL, May 06, 2022 (GLOBE NEWSWIRE) — Dorel Industries Inc. (TSX: DII.B, DII.A) today released results for the first quarter ended March 31, 2022. “First quarter challenges generally mirrored those of the previous quarter. Supply chain issues, high inflation as well as its impact on pricing and our consumers and uncertainty in Europe all contributed to lower earnings in the quarter. Sales at Dorel Home declined versus prior year as consumers made fewer purchases of home office furniture with the easing of Covid-19 and retail price points increased. At Dorel Juvenile, retail price points increased as well, but demand remained strong in most markets. We have implemented price increases in both...

Continue reading

Chicago Atlantic Real Estate Finance Schedules First Quarter 2022 Earnings Release and Conference Call Dates

CHICAGO, May 06, 2022 (GLOBE NEWSWIRE) — Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI) (“Chicago Atlantic” or the “Company”), a commercial real estate finance company, announced details for the release of its results for the first quarter ended March 31, 2022. The Company plans to issue its earnings release before the market opens on Thursday, May 12, 2022, and will host a conference call and live audio webcast, both open for the general public to hear, later that day at 10:00 a.m. Eastern Time. The number to call for this interactive teleconference is (866) 374-5140 (international callers: (404) 374-5140). The conference PIN is 32070938#. The live audio webcast of the Company’s quarterly conference call will be available online in the Investor Relations section of the Company’s website at investors.refi.reit....

Continue reading

Intercept Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update

Worldwide Ocaliva® net sales of $88.6 million, representing 8% growth over the prior year quarter Nearing completion of new REGENERATE data analyses; planning for potential pre-submission meeting with FDA in June Continue to expect topline results from Phase 3 REVERSE study in compensated cirrhosis due to NASH in Q3 Advanz Pharma to acquire Ocaliva® (obeticholic acid) in PBC markets outside the U.S. for up to $450MM, including $405MM upfront and an additional $45MM in contingent payments Company to host conference call today at 8:30 a.m. ET MORRISTOWN, N.J, May 06, 2022 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced its financial results for the quarter...

Continue reading

Telesat Reports Results for the Quarter Ended March 31, 2022

OTTAWA, May 06, 2022 (GLOBE NEWSWIRE) — Telesat (NASDAQ and TSX: TSAT), one of the world’s largest and most innovative satellite operators, today announced its financial results for the three-month period ended March 31, 2022. All amounts are in Canadian dollars and reported under International Financial Reporting Standards (“IFRS”) unless otherwise noted. “We had a busy first quarter and it sets us up well to achieve our objectives for the rest of the year and beyond,” commented Dan Goldberg, Telesat’s President and CEO. “We signed an important partial renewal with the DISH Network and entered into another agreement to support broadband connectivity for the cruise industry that makes use of virtually all of the capacity that Dish did not renew. We also took advantage of the discounted price of Telesat’s senior unsecured notes...

Continue reading

The Tile Shop Reports First Quarter 2022 Results

MINNEAPOLIS, May 06, 2022 (GLOBE NEWSWIRE) — Tile Shop Holdings, Inc. (Nasdaq: TTSH) (the “Company”), a specialty retailer of natural stone and man-made tiles, today announced results for its first quarter ended March 31, 2022. First Quarter Summary Net Sales Increased 11.3%Comparable Store Sales Increased 10.7% Gross Margin of 65.2%Net income of $3.5 Million; Adjusted EBITDA of $11.7 MillionDiluted Earnings per Share of $0.07 Management Commentary – Cabell Lolmaugh, CEO “We are pleased with our continued strong topline performance. We eclipsed $100 million of sales in a quarter for the first time in our history and this marks our fourth consecutive quarterly sales record,” stated Cabell Lolmaugh, CEO. “While our store sales productivity continues to improve, inflationary cost pressures had an adverse impact on our gross margin...

Continue reading

Broadwind Announces First Quarter 2022 Results

CICERO, Ill., May 06, 2022 (GLOBE NEWSWIRE) — Broadwind (NASDAQ: BWEN, or the “Company”), a diversified precision manufacturer of specialized components and solutions serving global markets, today announced results for the first quarter 2022. FIRST QUARTER 2022 RESULTS(As compared to the first quarter 2021)Total revenue of $41.8 million, +28% y/y Heavy Fabrications segment revenue of $27.3 million +20% y/y Gearing segment revenue of $10.6 million, +98% y/y Total net loss of ($2.4 million) or ($0.12) per basic share Total orders of $52.7 million, +54% y/y Total backlog of $117.1 million, +24% y/y Total cash and excess availability of $14.7 millionFor the three months ended March 31, 2022, the Company reported total revenue of $41.8 million, an increase of 28% when compared to the prior year period. The Company reported a net...

Continue reading

Sprott Announces First Quarter 2022 Results

TORONTO, May 06, 2022 (GLOBE NEWSWIRE) — Sprott Inc. (NYSE/TSX: SII) (“Sprott” or the “Company”) today announced its financial results for the quarter ended March 31, 2022. Management commentary “Sprott continued to deliver outstanding financial results in the first quarter of 2022, as Assets Under Management (“AUM”) increased to $23.7 billion, up $3.2 billion (16%) from December 31, 2021. Net income was $6.5 million ($0.26 per share), up $3.3 million ($0.13 per share) from the quarter ended March 31, 2021. Adjusted base EBITDA was $18.2 million ($0.73 per share), up 24%, or $3.6 million ($0.14 per share) from the quarter ended March 31, 2021. Our strong operating performance during the quarter was driven by market value appreciation in our uranium, gold and silver strategies and more than $1.3 billion of inflows to our...

Continue reading

Interim Financial Report Q1 2022: record start to the year in challenging market drives guidance upgrade

Today, the Board of Directors of H+H International A/S (hereinafter referred to as “H+H” or “the Group”) has adopted the Interim Financial Report for the first quarter of 2022 (“Q1 2022”). CEO MICHAEL T. ANDERSEN QUOTE “The first quarter showed solid financial performance with organic growth of 29 percent underpinning the successful implementation of sales price increases to counter the inflationary pressure on production cost and the negative impact on margins. This was further highlighted by a record-high EBIT before special items and a strong margin of 13 percent for the quarter. We expect the inflationary pressure to remain in place in the short-to-medium term, and we are ready to introduce further sales price increases to protect our earnings margins.” PERFORMANCE HIGHLIGHTS FOR Q1 2022 (Q1 2021)Revenue increased by 36% to DKK 874...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.